Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,269 GBX | +1.43% | +0.23% | +15.79% |
11:13am | London stocks open lower amid Fed's cautious stance | |
10:56am | ASTRAZENECA : Receives a Sell rating from UBS | ZD |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.79% | 238B | |
+34.35% | 705B | |
+30.55% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
-3.44% | 210B | |
+10.45% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Transcript : AstraZeneca PLC Presents at 45tháSan Antonio Breast Cancer Symposium 2022, Dec-06-2022 through Dec-10-2022